Literature DB >> 15339915

Recurrent fever promotes Plasmodium falciparum development in human erythrocytes.

Soundara Raghavan Pavithra1, Gowrishankar Banumathy, Omana Joy, Varsha Singh, Utpal Tatu.   

Abstract

The human malarial parasite Plasmodium falciparum (Pf) is exposed to wide temperature fluctuations during its life cycle, ranging from 25 degrees C in the mosquito vector and 37 degrees C in humans to 41 degrees C during febrile episodes in the patient. The repeated occurrence of fever at regular intervals is a characteristic of human malaria. We have examined the influence of repeated exposure to elevated temperatures encountered during fever on the intraerythrocytic development of the parasite. Using flow cytometry, we show that repeated exposure to temperatures mimicking febrile episodes promotes parasite development in human erythrocytes. Heat shock-mediated cytoprotection and growth promotion is dependent on the heat shock protein 90 (PfHsp90) multi-chaperone complex. Inhibition of PfHsp90 function using geldanamycin attenuates temperature-dependent progression from the ring to the trophozoite stage. Geldanamycin inhibits parasite development by disrupting the PfHsp90 complex consisting of PfHsp70, PfPP5, and tubulin, among other proteins. While explaining the contribution of febrile episodes to the pathogenesis of malaria, our results implicate temperature as an important environmental cue used by the parasite to coordinate its development in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15339915     DOI: 10.1074/jbc.M409165200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Whither genome research: of man, mosquito and malaria.

Authors:  Utpal Tatu; Samta Jain; P Padma Priya
Journal:  J Biosci       Date:  2005-12       Impact factor: 1.826

2.  Characterization of Plasmodium vivax heat shock protein 70 and evaluation of its value for serodiagnosis of tertian malaria.

Authors:  Byoung-Kuk Na; Jae-Won Park; Hyeong-Woo Lee; Klin Lin; Seon-Hee Kim; Young-An Bae; Woon-Mok Sohn; Tong-Soo Kim; Yoon Kong
Journal:  Clin Vaccine Immunol       Date:  2007-01-17

3.  Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria.

Authors:  Ranjit Kumar; Soundara Raghavan Pavithra; Utpal Tatu
Journal:  J Biosci       Date:  2007-04       Impact factor: 1.826

Review 4.  Chaperoning erythropoiesis.

Authors:  Mitchell J Weiss; Camila O dos Santos
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

5.  Cloning of Plasmodium falciparum by single-cell sorting.

Authors:  Jun Miao; Xiaolian Li; Liwang Cui
Journal:  Exp Parasitol       Date:  2010-05-18       Impact factor: 2.011

6.  Post-transcriptional repair of a split heat shock protein 90 gene by mRNA trans-splicing.

Authors:  Rishi Kumar Nageshan; Nainita Roy; Adrian B Hehl; Utpal Tatu
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

7.  Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin.

Authors:  Dea Shahinas; Gregory Macmullin; Christan Benedict; Ian Crandall; Dylan R Pillai
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 8.  The structural and functional diversity of Hsp70 proteins from Plasmodium falciparum.

Authors:  Addmore Shonhai; Aileen Boshoff; Gregory L Blatch
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

9.  Unlike the synchronous Plasmodium falciparum and P. chabaudi infection, the P. berghei and P. yoelii asynchronous infections are not affected by melatonin.

Authors:  Piero Bagnaresi; Eduardo Alves; Henrique Borges da Silva; Sabrina Epiphanio; Maria M Mota; Célia Rs Garcia
Journal:  Int J Gen Med       Date:  2009-07-30

10.  The effect of mimicking febrile temperature and drug stress on malarial development.

Authors:  Ratchaneewan Aunpad; Sangdao Somsri; Kesara Na-Bangchang; Rachanee Udomsangpetch; Mathirut Mungthin; Poom Adisakwattana; Wanna Chaijaroenkul
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-12       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.